Skip to content
    F

    Fairmount

    Conshohocken, Pennsylvania, United StatesFounded 1998
    Biotech & Life Sciences

    Fairmount is a Series B to growth stage investment firm based in Conshohocken, Pennsylvania, United States. It has made 4 investments, with focus areas including Biotech & Life Sciences. 100% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is growth (75% of deals). Average disclosed round size is $248.5M (across 4 rounds with reported amounts).

    Find people at Fairmount on Goldilocks AI

    Portfolio

    4

    Fund Size

    $3.2B

    Top Stage

    Growth

    Last 12 Mo

    1

    Portfolio Breakdown

    Stage Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    4 investments
    CompanyRoundAmountDate
    Crescent Biopharma logoCrescent BiopharmaGrowth$200MJun 2025
    Apogee Therapeutics logoApogee TherapeuticsSeries B$149MDec 2022
    OOruka TherapeuticsGrowth$275M—
    Candid Therapeutics logoCandid TherapeuticsGrowth$370M—

    Top Co-Investors

    Venrock Healthcare Capital Partners4 shared
    Deep Track Capital3 shared
    RTW Investments2 shared
    Commodore Capital2 shared
    Perceptive Advisors2 shared
    Braidwell LP2 shared
    Wellington Management2 shared
    Access Biotechnology1 shared
    Avidity Partners1 shared
    Redmile Group1 shared
    venBio1 shared
    Fidelity Management & Research Company1 shared
    OrbiMed1 shared
    RA Capital Management1 shared
    BVF Partners LP1 shared
    Paradigm BioCapital1 shared
    Blackstone Inc.1 shared
    Frazier Life Sciences1 shared
    Soleus Capital1 shared
    Logos Capital1 shared

    Last updated: 10 April 2026